Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
7.45
-0.09 (-1.19%)
Nov 18, 2026, 1:23 PM EST - Market open
Xilio Therapeutics Employees
Xilio Therapeutics had 76 employees as of December 31, 2025. The number of employees increased by 12 or 18.75% compared to the previous year. That makes Xilio Therapeutics the 33,059th largest employer in the world and 4,299th in the United States.
Employees
76
Change (1Y)
12
Growth (1Y)
18.75%
Revenue / Employee
$723,816
Profits / Employee
-$151,184
Market Cap
52.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 76 | 12 | 18.75% |
| Dec 31, 2024 | 64 | -9 | -12.33% |
| Mar 31, 2024 | 56 | -33 | -37.08% |
| Dec 31, 2023 | 73 | -16 | -17.98% |
| Sep 30, 2023 | 81 | -8 | -8.99% |
| Jun 30, 2023 | 84 | 6 | 7.69% |
| Mar 31, 2023 | 89 | 11 | 14.10% |
| Dec 31, 2022 | 89 | 15 | 20.27% |
| Mar 31, 2022 | 78 | 21 | 36.84% |
| Dec 31, 2021 | 74 | 17 | 29.82% |
| Sep 30, 2021 | 69 | - | - |
| Jun 30, 2021 | 66 | - | - |
| Mar 31, 2021 | 57 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Clene | 79 |
| MindWalk Holdings | 77 |
| Oncolytics Biotech | 29 |
| Spero Therapeutics | 25 |
| iBio, Inc. | 23 |
| Gain Therapeutics | 21 |
| RenovoRx | 17 |
| MiNK Therapeutics | 15 |
XLO News
- 7 days ago - Xilio Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 8 days ago - Xilio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Pipeline and Business Updates - GlobeNewsWire
- 8 days ago - Xilio Therapeutics Quarterly report: Q3 2026 - Filings
- 8 days ago - Xilio Therapeutics Earnings release: Q3 2026 - Filings
- 14 days ago - Xilio Therapeutics to Present at the Stifel 2026 Healthcare Conference - GlobeNewsWire
- 19 days ago - Xilio Therapeutics Inc trading resumes - TheFly
- 19 days ago - Xilio Therapeutics Inc trading halted, volatility trading pause - TheFly
- 23 days ago - Xilio Therapeutics doses first patient in XTX501 trial - TheFly